Showing 1 - 10 of 333
A Faustian bargain for the Global South
Oped, Published on 05/08/2025
» US President Donald Trump's tariff policies have unleashed global economic turmoil and a wave of protectionist measures. While many of his frequently changing tariffs may prove short-lived, their use as geopolitical weapons is poised to reshape international trade for years to come.
New drug to be registered with FDA
News, Apinya Wipatayotin, Published on 04/07/2025
» The Government Pharmaceutical Organisation (GPO) has prepared to register the affordable hepatitis C drug ravidasvir with the Food and Drug Administration to improve access for 800,000 patients and reduce treatment costs.
Thailand clears plan to exit US intellectual property watchlist
Published on 27/05/2025
» Thailand’s cabinet has approved a new framework for enforcement of intellectual property rights as the country seeks to exit from a US watchlist ahead of tariff talks with Washington.
Unite to solve neglected diseases
Oped, Published on 29/04/2025
» The successful collaboration between the health ministries of Malaysia and Thailand, industry partners in Egypt and Malaysia, and the Drugs for Neglected Diseases initiative (DNDi) to bring a new hepatitis C antiviral drug -- ravidasvir -- to market in 2022 was an important milestone. For years, a 12-week course of treatment using sofosbuvir cost between $70,000 (2.34 million baht) and $80,000, putting it out of reach for many in the Global South. But ravidasvir -- a safe and effective alternative when combined with sofosbuvir -- costs far less, averaging less than $500 per course.
A mutually beneficial pact
Business, Published on 31/03/2025
» On March 13, the European Parliament adopted a resolution condemning Thailand for deporting Uyghurs to China. Members also urged the European Commission to leverage ongoing free trade agreement (FTA) negotiations to press Thailand to reform its lese majeste laws, release political prisoners, and cease the deportation of Uyghurs.
Thailand Expands Vaccine Procurement for Young Children
Published on 27/02/2025
» The National Vaccine Committee has approved, in principle, the implementation of policies supporting local administrative organizations in procuring influenza vaccines and pneumococcal conjugate vaccines (PCV) for children under the age of five. This initiative aims to reduce severe illness and mortality from vaccine-preventable diseases.
Cancer patients are dying to survive
News, Supara Janchitfah, Published on 07/02/2025
» As a university law lecturer, Nat is struggling to make ends meet. Her monthly salary of 33,000 baht is only a fraction of the cost of the super-expensive cancer drug she has been taking.
WHO certifies Thai facility for HIV medication
News, Published on 05/01/2025
» The World Health Organization (WHO) has certified the Government Pharmaceutical Organization's (GPO) facility in Pathum Thani under the WHO Prequalification Programme (WHO PQ) for manufacturing the antiretroviral drug Efavirenz.
National Vaccine Institute Marks 12 Years of Vaccine Leadership
Published on 06/09/2024
» August 11th marks the anniversary of the founding of National Vaccine Institute (NVI), which celebrates its 12th year in 2024. NVI was established with the mission of supporting the country's comprehensive vaccine efforts, spanning from early research and development to distribution and administration. NVI's work is guided by the National Vaccine Security Strategy, ensuring that Thailand has a sufficient and continuous supply of vaccines in both normal and outbreak situations.